Lexeo Therapeutics, Inc. (LXEO)
9.74
-0.53
(-5.16%)
USD |
NASDAQ |
Dec 30, 16:00
9.715
-0.02
(-0.26%)
After-Hours: 20:00
Lexeo Therapeutics EPS Diluted (Quarterly): -0.3326 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Anixa Biosciences, Inc. | -0.0695 |
| GT Biopharma, Inc. | -0.8268 |
| Moleculin Biotech, Inc. | -17.02 |
| Phathom Pharmaceuticals, Inc. | -0.4084 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -20.28M |
| Total Expenses (Quarterly) | 20.28M |
| Enterprise Value | 208.98M |
| Earnings Yield | -27.74% |
| Normalized Earnings Yield | -27.74 |